Article

Allergan supports PBA advocacy

After many years as a partner and supporter of Prevent Blindness America (PBA), Allergan Inc. has awarded PBA an advocacy grant to provide funding for The Eye Care Advocacy Network (Eye CAN).

Chicago-After many years as a partner and supporter of Prevent Blindness America (PBA), Allergan Inc. has awarded PBA an advocacy grant to provide funding for The Eye Care Advocacy Network (Eye CAN).

Eye CAN is the advocacy home for PBA and its efforts to encourage local community members and leaders to promote vision and eye health through legislation and advocacy. The Web site (http://www.preventblindness.org/advocacy) will give recognition to advocates and include federal and state legislative updates. It will also serve as a forum for success stories and words of advice to help build a strong, dedicated team of eye health advocates.

“Allergan continues to be a proud partner of PBA and their sight-saving programs that seek to provide much needed eye care services to those in our own communities,” said Julian Gangolli, corporate vice president, president, North America Pharmaceuticals of Allergan. “Through advocacy and public health outreach, we work together to educate our nation’s leaders, as well as the public, on the importance of eye health.”

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.